BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rumlová M, Ruml T. In vitro methods for testing antiviral drugs. Biotechnol Adv 2018;36:557-76. [PMID: 29292156 DOI: 10.1016/j.biotechadv.2017.12.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Osuna-Ramos JF, Reyes-Ruiz JM, Del Ángel RM. The Role of Host Cholesterol During Flavivirus Infection. Front Cell Infect Microbiol 2018;8:388. [PMID: 30450339 DOI: 10.3389/fcimb.2018.00388] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 12.0] [Reference Citation Analysis]
2 Tian H, He B, Yin Y, Liu L, Shi J, Hu L, Jiang G. Chemical Nature of Metals and Metal-Based Materials in Inactivation of Viruses. Nanomaterials (Basel) 2022;12:2345. [PMID: 35889570 DOI: 10.3390/nano12142345] [Reference Citation Analysis]
3 Reichling J. Antiviral and Virucidal Properties of Essential Oils and Isolated Compounds - A Scientific Approach. Planta Med 2021. [PMID: 34144626 DOI: 10.1055/a-1382-2898] [Reference Citation Analysis]
4 Li Z, Wang F, Ying Q, Kong D, Zhang X, Dong Y, Liu Y, Zhai D, Chen Z, Jia M, Xue X, Li M, Wu X. In vitro Anti-Hantavirus Activity of Protein Kinase Inhibitor 8G1 Targeting AKT/mTOR/eIF4E Signaling Pathway. Front Microbiol 2022;13:880258. [DOI: 10.3389/fmicb.2022.880258] [Reference Citation Analysis]
5 Ruml T. The Present and Future of Virology in the Czech Republic-A New Phoenix Made of Ashes? Viruses 2022;14:1303. [PMID: 35746773 DOI: 10.3390/v14061303] [Reference Citation Analysis]
6 Hozáková L, Vokatá B, Ruml T, Ulbrich P. Targeting the Virus Capsid as a Tool to Fight RNA Viruses. Viruses 2022;14:174. [DOI: 10.3390/v14020174] [Reference Citation Analysis]
7 Khwaza V, Oyedeji OO, Aderibigbe BA. Antiviral Activities of Oleanolic Acid and Its Analogues. Molecules. 2018;23. [PMID: 30205592 DOI: 10.3390/molecules23092300] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
8 Mehyar N, Mashhour A, Islam I, Alhadrami HA, Tolah AM, Alghanem B, Alkhaldi S, Somaie BA, Al Ghobain M, Alobaida Y, Alaskar AS, Boudjelal M. Discovery of Zafirlukast as a novel SARS-CoV-2 helicase inhibitor using in silico modelling and a FRET-based assay. SAR QSAR Environ Res 2021;32:963-83. [PMID: 34818959 DOI: 10.1080/1062936X.2021.1993995] [Reference Citation Analysis]
9 Santos JD, Vitorino I, Reyes F, Vicente F, Lage OM. From Ocean to Medicine: Pharmaceutical Applications of Metabolites from Marine Bacteria. Antibiotics (Basel) 2020;9:E455. [PMID: 32731464 DOI: 10.3390/antibiotics9080455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Idriss H, Siddig B, Maldonado PG, Elkhair HM, Alakhras AI, Abdallah EM, Torres PHS, Elzupir AO. Phytochemical Discrimination, Biological Activity and Molecular Docking of Water-Soluble Inhibitors from Saussurea costus Herb against Main Protease of SARS-CoV-2. Molecules 2022;27:4908. [DOI: 10.3390/molecules27154908] [Reference Citation Analysis]
11 Rietdijk J, Tampere M, Pettke A, Georgiev P, Lapins M, Warpman-Berglund U, Spjuth O, Puumalainen MR, Carreras-Puigvert J. A phenomics approach for antiviral drug discovery. BMC Biol 2021;19:156. [PMID: 34334126 DOI: 10.1186/s12915-021-01086-1] [Reference Citation Analysis]
12 Delcanale P, Abbruzzetti S, Viappiani C. Photodynamic treatment of pathogens. Riv Nuovo Cim . [DOI: 10.1007/s40766-022-00031-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Arista-Romero M, Pujals S, Albertazzi L. Towards a Quantitative Single Particle Characterization by Super Resolution Microscopy: From Virus Structures to Antivirals Design. Front Bioeng Biotechnol 2021;9:647874. [PMID: 33842446 DOI: 10.3389/fbioe.2021.647874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wiehe A, O'Brien JM, Senge MO. Trends and targets in antiviral phototherapy. Photochem Photobiol Sci 2019;18:2565-612. [PMID: 31397467 DOI: 10.1039/c9pp00211a] [Cited by in Crossref: 78] [Cited by in F6Publishing: 36] [Article Influence: 26.0] [Reference Citation Analysis]
15 Xu T, Zheng W, Huang R. High-throughput screening assays for SARS-CoV-2 drug development: Current status and future directions. Drug Discov Today 2021:S1359-6446(21)00244-0. [PMID: 34048893 DOI: 10.1016/j.drudis.2021.05.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 García-Murria MJ, Expósito-Domínguez N, Duart G, Mingarro I, Martinez-Gil L. A Bimolecular Multicellular Complementation System for the Detection of Syncytium Formation: A New Methodology for the Identification of Nipah Virus Entry Inhibitors. Viruses 2019;11:E229. [PMID: 30866435 DOI: 10.3390/v11030229] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
17 Dostálková A, Škach K, Kaufman F, Křížová I, Hadravová R, Flegel M, Ruml T, Hrabal R, Rumlová M. PF74 and Its Novel Derivatives Stabilize Hexameric Lattice of HIV-1 Mature-Like Particles. Molecules 2020;25:E1895. [PMID: 32325987 DOI: 10.3390/molecules25081895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Křížová I, Dostálková A, Castro E, Prchal J, Hadravová R, Kaufman F, Hrabal R, Ruml T, Llano M, Echegoyen L, Rumlová M. Fullerene Derivatives Prevent Packaging of Viral Genomic RNA into HIV-1 Particles by Binding Nucleocapsid Protein. Viruses 2021;13:2451. [PMID: 34960720 DOI: 10.3390/v13122451] [Reference Citation Analysis]
19 Li Z, Kong D, Liu Y, Li M. Pharmacological perspectives and molecular mechanisms of coumarin derivatives against virus disease. Genes Dis 2022;9:80-94. [PMID: 35005109 DOI: 10.1016/j.gendis.2021.03.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
20 Al Adem K, Shanti A, Stefanini C, Lee S. Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules.Pharmaceuticals (Basel). 2020;13. [PMID: 33302344 DOI: 10.3390/ph13120447] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Mukundan S, Bhatt R, Lucas J, Tereyek M, Chang TL, Subbian S, Parekkadan B. 3D host cell and pathogen-based bioassay development for testing anti-tuberculosis (TB) drug response and modeling immunodeficiency. Biomol Concepts 2021;12:117-28. [PMID: 34473918 DOI: 10.1515/bmc-2021-0013] [Reference Citation Analysis]
22 Kaufman F, Dostálková A, Pekárek L, Thanh TD, Kapisheva M, Hadravová R, Bednárová L, Novotný R, Křížová I, Černý J, Grubhoffer L, Ruml T, Hrabal R, Rumlová M. Characterization and in vitro assembly of tick-borne encephalitis virus C protein. FEBS Lett 2020;594:1989-2004. [PMID: 32510601 DOI: 10.1002/1873-3468.13857] [Reference Citation Analysis]